Presenting enumeration of different CD45neg subgroups, as assessed by FACS, in blood samples obtained from healthy female donors, and Table S2B. presenting enumeration of different CD45neg subgroups, as assessed by DEPArray, in blood samples obtained from healthy female donors. (DOCX 90 kb
Clinical response rate and pathological response rate to neoadjuvant chemotherapy. (DOCX 11 kb
Kaplan-Meier analysis of clinico-pathological parameters in older patients. (DOCX 17Â kb
Supplementary information: power calculation performed before initiation of the study. (PDF 483 kb
Figure S1. CTC count as a continuous variable in relation to presence of CTC clusters. (PDF 182 kb
Table S3. Change in CTC count in relation to progression versus non-progression at first radiologica...
Table S4. Unadjusted Cox regression analyses of patient and tumor characteristics at baseline. (PDF ...
Table S1. Primer and probe sequences used for qPCR assay for the detection of CTC in blood obtained ...
Clinico-pathological characteristics of younger and older patients. (DOCX 15Â kb
Table S2. FOXP3 levels distribution according to tumor subtype and clinicopathological features. (DO...
Tumor, lymph node, metastasis (TNM) classification for defining subgroups of patients with locally a...
Biomarkers and RDIâ<â85% in overall patients vs. adjuvant patients. (DOC 31Â kb
Table S1. Overview of clinical characteristics of the patient and tumour information stratified by t...
Figure S4. (A) Survival analyses (time to systemic relapse/breast cancer death) in relation to NR2F1...
Table S8. Complete blood counts in patients with single circulating tumor cells and circulating tumo...
Table S1. CD8 levels distribution according to tumor subtype and clinicopathological features. (DOCX...
Clinical response rate and pathological response rate to neoadjuvant chemotherapy. (DOCX 11 kb
Kaplan-Meier analysis of clinico-pathological parameters in older patients. (DOCX 17Â kb
Supplementary information: power calculation performed before initiation of the study. (PDF 483 kb
Figure S1. CTC count as a continuous variable in relation to presence of CTC clusters. (PDF 182 kb
Table S3. Change in CTC count in relation to progression versus non-progression at first radiologica...
Table S4. Unadjusted Cox regression analyses of patient and tumor characteristics at baseline. (PDF ...
Table S1. Primer and probe sequences used for qPCR assay for the detection of CTC in blood obtained ...
Clinico-pathological characteristics of younger and older patients. (DOCX 15Â kb
Table S2. FOXP3 levels distribution according to tumor subtype and clinicopathological features. (DO...
Tumor, lymph node, metastasis (TNM) classification for defining subgroups of patients with locally a...
Biomarkers and RDIâ<â85% in overall patients vs. adjuvant patients. (DOC 31Â kb
Table S1. Overview of clinical characteristics of the patient and tumour information stratified by t...
Figure S4. (A) Survival analyses (time to systemic relapse/breast cancer death) in relation to NR2F1...
Table S8. Complete blood counts in patients with single circulating tumor cells and circulating tumo...
Table S1. CD8 levels distribution according to tumor subtype and clinicopathological features. (DOCX...
Clinical response rate and pathological response rate to neoadjuvant chemotherapy. (DOCX 11 kb
Kaplan-Meier analysis of clinico-pathological parameters in older patients. (DOCX 17Â kb
Supplementary information: power calculation performed before initiation of the study. (PDF 483 kb